Literature DB >> 29146183

D Rhamnose β-hederin inhibits migration and invasion of human breast cancer cell line MDA-MB-231.

Lin Cheng1, Tian-Song Xia2, Liang Shi2, Lingyun Xu3, Weixian Chen3, Yulan Zhu4, Qiang Ding5.   

Abstract

Many natural products have been shown to have inhibitory effects on the metastatic process of various cancers including breast cancer. An active triterpenoid saponin D Rhamnose β-hederin (DRβ-H) from Clematis ganpiniana, has been known induce the apoptosis of breast cancer cells, but the effect of DRβ-H on the metastasis of breast cancer cells is largely unknown. In this study, we demonstrated that a non-cytotoxic concentration of DRβ-H markedly suppressed wound healing migration, migration through the chamber and invasion through the matrigel. In addition, DRβ-H regulated expression of RNPC1, E-cadherin proteins of MDA-MB-231 cells. Furthermore, RNPC1 knockdown decreased the DRβ-H-induced up-regulation of RNPC1 and E-Cadherin in MDA-MB-231 cells. RNPC1 knockdown reduced the anti-metastasis activities of DRβ-H, meaning that the up-rugulation of RNPC1 by DRβ-H is essential for its anti-metastatis activities. These results suggest that DRβ-H might be a potential therapeutic candidate for the treatment of breast cancer metastasis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; D Rhamnose β-hederin; Mechanism; Metastasis; RNPC1; Triterpenoid saponins

Mesh:

Substances:

Year:  2017        PMID: 29146183     DOI: 10.1016/j.bbrc.2017.11.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission.

Authors:  Wei-Xian Chen; Ling-Yun Xu; Qi Qian; Xiao He; Wen-Ting Peng; Wen-Qiang Fan; Yu-Lan Zhu; Jin-Hai Tang; Lin Cheng
Journal:  Biosci Rep       Date:  2018-09-28       Impact factor: 3.840

Review 2.  OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.

Authors:  Khalid Otmani; Redouane Rouas; Philippe Lewalle
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.